Month: February 2021

Feb 12 2021

Uncategorized

We Need To Talk About the Potential Link Between COVID-19 and Schizophrenia

by Clinical Editor

No Comments

Neuroscience student Brian Fu discusses recent research that suggests a potential link between mortality due to the coronavirus (COVID-19) and schizophrenia or associated spectrum disorders.

Feb 12 2021

Uncategorized

The microRNA-195 – BDNF pathway and cognitive deficits in schizophrenia patients with minimal antipsychotic medication exposure

by Clinical Editor

No Comments

Cognitive impairment is a core characteristic of schizophrenia, but its underlying neural mechanisms remain poorly understood. Reduced brain-derived neurotrophic factor (BDNF), a protein critical for …

Feb 11 2021

Uncategorized

Non-Stimulant ADHD NDA Resubmitted; Schizophrenia or Viral Encephalitis?

by Clinical Editor

No Comments

A General Psychiatry case reports details the story of a male patient, age 16 years, who was hospitalized, diagnosed with schizophrenia, and then treated with aripiprazole (Abilify), only to find...

Feb 11 2021

Uncategorized

Schizophrenia Drugs Market Analysis, Geographical Segmentation, Drivers, Challenges, Trends and Forecast 2020 – 2027

by Clinical Editor

No Comments

The report analyzes and forecasts the Schizophrenia Drugs market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2020 to...

Feb 11 2021

Uncategorized

People with schizophrenia are more likely to die of COVID-19

by Clinical Editor

No Comments

A new study reveals that people with schizophrenia are almost three times more likely to die if diagnosed with COVID-19 than individuals who do not have that mental illness. More...

Feb 11 2021

Uncategorized

Severe Covid-19 Patients With Schizophrenia Might Be At A Higher Risk Of Dying

by Clinical Editor

No Comments

A schizophrenia spectrum diagnosis could be at a higher risk of severe Covid-19 and might also face 2.7 times higher risk for mortality within 45 days of testing positive, according...

Feb 11 2021

Uncategorized

The microRNA-195 – BDNF pathway and cognitive deficits in schizophrenia patients with minimal antipsychotic medication exposure

by Clinical Editor

No Comments

Cognitive impairment is a core characteristic of schizophrenia, but its underlying neural mechanisms remain poorly understood. Reduced brain-derived neurotrophic factor (BDNF), a protein critical for …

Feb 10 2021

Uncategorized

The microRNA-195 – BDNF pathway and cognitive deficits in schizophrenia patients with minimal antipsychotic medication exposure

by Clinical Editor

No Comments

Cognitive impairment is a core characteristic of schizophrenia, but its underlying neural mechanisms remain poorly understood. Reduced brain-derived neurotrophic factor (BDNF), a protein critical for …

Feb 10 2021

Uncategorized

We Need To Talk About the Potential Link Between COVID-19 and Schizophrenia

by Clinical Editor

No Comments

Neuroscience student Brian Fu discusses recent research that suggests a potential link between mortality due to the coronavirus (COVID-19) and schizophrenia or associated spectrum disorders.

Feb 10 2021

Uncategorized

People with schizophrenia are more likely to die of COVID-19

by Clinical Editor

No Comments

A new study reveals that people with schizophrenia are almost three times more likely to die if diagnosed with COVID-19 than individuals who do not have that mental illness. More...